Day: August 26, 2024

MELBOURNE, Australia, Aug. 27, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces new leadership appointments as part of an internal reorganisation to align its operations across four business units, reflecting its focus as a therapeutics-led radiopharmaceutical company committed to precision oncology. The updated business model comprises: Therapeutics, Precision Medicine (Diagnostics), Lightpoint (Medtech) and Telix Manufacturing Solutions (TMS). As part of this initiative, the Company announces three leadership changes: Richard Valeix, Chief Executive Officer, Telix Therapeutics (formerly Group Chief Commercial Officer)1, leading the Company’s therapeutic pipeline commercialisation and business development; Kevin Richardson, Chief Executive Officer, Telix Precision Medicine...

INSIDE INFORMATION La Hulpe, Belgium – August 26, 2024, Midnight– [INSIDE INFORMATION] Unifiedpost Group (Euronext Brussels: UPG) (Unifiedpost), a leading provider of integrated business communication solutions, announces the signing of a binding term sheet (Term Sheet) with Your.World B.V. (Your.World) for the sale of its Wholesale Identity Access business in the Netherlands (the Transaction). The Term Sheet outlines the sale of all shares in Unifiedpost B.V., following the carve-out of its non-Wholesale Identity Access business, for a base purchase price based on an enterprise value of € 133,0 million on a cash and debt-free basis, which includes an earn-out payment of up to € 7,7 million upon achieving certain financial milestones. The Transaction is part of a wider, new strategic partnership which is to be entered into between Unifiedpost...

Oslo, 26 August 2024 Interoil Exploration and Production ASA (the “Company“) announces that its Colombian subsidiary, Interoil Colombia Exploration and Production (“ICEP”), has reached an agreement with the Colombian National Hydrocarbons Agency –Agencia Nacional de Hidrocarburos– (the “ANH”) for a partial termination of the Exploration and Production contract between ICEP and the ANH over the LLA-47 block (the “LLA-47 Contract”). This contract termination is predicated upon the difficulties related to community’s unflinching opposition to exploration activities that have prevented normal development of activities and satisfaction of exploratory commitments for an extensive period of time, which motivated several time extensions and suspensions granted by the ANH to contract term. Under such partial termination,...

TEL AVIV, Israel, Aug. 26, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. The presentation will begin at 11:30 A.M. Eastern Time. To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations. An archived version of the webcast will be available within 24 hours after the end of the live discussion. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery,...